Sabine Bisson
CIK: 0002152874
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RTSN
Retension Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Bisson Sabine
Bisson Sabine (SEC CIK 0002152874) files insider reports with the SEC as CHIEF OPERATING OFFICER of Retension Pharmaceuticals, Inc. (RTSN).
Signal8 holds 2 ownership filings by Bisson Sabine (1 Form 3, 1 Form 4), filed between Oct 8, 2026 and Oct 13, 2026. Those filings report 2 transactions, the latest on Oct 13, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bisson Sabine's filings is in FALLS CHURCH, VA.
Recent filings by Bisson Sabine
- Oct 13, 2026: Conversions of RTSN shares (2 lines, Form 4, code C).
Other insiders filing for Retension Pharmaceuticals, Inc. (RTSN)
- Keller Eric L., CHIEF EXECUTIVE OFFICER
- B Group, Inc., 10% Owner
- Sweetnam Paul, CHIEF SCIENTIFIC OFFICER
- Olds Donald, Director
- Cheruvu Pavan, Director
- BERGER FRANKLIN M, Director